Published in PLoS One on June 03, 2016
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet (2005) 6.36
Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res (2001) 4.38
Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet (2007) 4.23
Age-related macular degeneration. Lancet (2012) 4.17
Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet (2008) 4.16
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet (2011) 3.55
Age-related macular degeneration. Lancet (2008) 3.34
Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet (2008) 3.29
Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A (2006) 3.25
Familial aggregation of age-related maculopathy. Am J Ophthalmol (1997) 2.77
Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31
Allergy is a protective factor against age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 2.09
Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology (2011) 1.96
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet (2007) 1.67
Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2011) 1.42
A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet (2013) 1.29
Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am J Hum Genet (2008) 1.27
Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol (1994) 1.22
The role of complement in AMD. Adv Exp Med Biol (2010) 1.21
Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology (2011) 1.20
A twin study of age-related macular degeneration. Am J Ophthalmol (1995) 1.14
Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.02
Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration. Hum Mol Genet (2014) 1.00
Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00
Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol (2001) 0.97
Grading of Age-Related Macular Degeneration: Comparison between Color Fundus Photography, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography. J Ophthalmol (2013) 0.96
Macular dystrophies mimicking age-related macular degeneration. Prog Retin Eye Res (2013) 0.87
Analysis of rare variants in the C3 gene in patients with age-related macular degeneration. PLoS One (2014) 0.87
Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene. Arch Ophthalmol (2012) 0.86
Age-related macular degeneration: the importance of family history as a risk factor. Br J Ophthalmol (2011) 0.85
ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study. Ophthalmology (2012) 0.84
Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. Mol Vis (2012) 0.82
Risk estimates for complex disorders: comparing personal genome testing and family history. Genet Med (2013) 0.81
Clinical characteristics of familial and sporadic age-related macular degeneration: differences and similarities. Invest Ophthalmol Vis Sci (2014) 0.79
Measures of body shape and adiposity as related to incidence of age-related eye diseases: observations from the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (2014) 0.78
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet (2015) 1.55
Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration. Am J Ophthalmol (2014) 0.95
Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels. PLoS One (2014) 0.92
Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology (2014) 0.88
A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration. PLoS One (2014) 0.84
Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times. Br J Ophthalmol (2016) 0.83
The genetics of age-related macular degeneration (AMD) - Novel targets for designing treatment options? Eur J Pharm Biopharm (2015) 0.83
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration. Sci Rep (2016) 0.82
Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration. Mol Vis (2015) 0.80
Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2015) 0.80
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol (2016) 0.80
Clinical characteristics of familial and sporadic age-related macular degeneration: differences and similarities. Invest Ophthalmol Vis Sci (2014) 0.79
Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Acta Ophthalmol (2015) 0.79
Rare Genetic Variants Associated With Development of Age-Related Macular Degeneration. JAMA Ophthalmol (2016) 0.78
Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration. Acta Ophthalmol (2015) 0.77
Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol (2015) 0.77
Genomic Copy Number Variations of the Complement Component C4B Gene Are Associated With Chronic Central Serous Chorioretinopathy. Invest Ophthalmol Vis Sci (2015) 0.77
A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab. Br J Ophthalmol (2015) 0.76
The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration. JAMA Ophthalmol (2016) 0.76
Nongenetic risk factors for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.76
Mutations in the polyglutamylase gene TTLL5, expressed in photoreceptor cells and spermatozoa, are associated with cone-rod degeneration and reduced male fertility. Hum Mol Genet (2016) 0.76
Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration. PLoS One (2016) 0.76
Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study. Acta Ophthalmol (2016) 0.76
Mutations in CTNNA1 cause butterfly-shaped pigment dystrophy and perturbed retinal pigment epithelium integrity. Nat Genet (2015) 0.75
Lipofuscin-associated photo-oxidative stress during fundus autofluorescence imaging. PLoS One (2017) 0.75
Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome. Clin Ophthalmol (2016) 0.75
Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages. PLoS One (2016) 0.75
Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy. Nature (2017) 0.75
Phenotype Characteristics of Patients With Age-Related Macular Degeneration Carrying a Rare Variant in the Complement Factor H Gene. JAMA Ophthalmol (2017) 0.75
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy. JAMA Ophthalmol (2017) 0.75
Multimodal imaging of the disease progression of birdshot chorioretinopathy. Acta Ophthalmol (2016) 0.75
Alteration of retinal layers in healthy subjects over 60 years of age until nonagenarians. Clin Ophthalmol (2017) 0.75
Physical Activity and Age-related Macular Degeneration: A systematic literature review and meta-analysis. Am J Ophthalmol (2017) 0.75
Aberrant leukocyte telomere length in Birdshot Uveitis. PLoS One (2017) 0.75